Juri Ruf

Karlsruhe, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.

PSMA-targeting hybrid molecule PSMA-914 for preoperative imaging and intraoperative fluorescence-guidance: A first-in-human experience.

Journal: Theranostics

Published: December 12, 2025

The differential diagnostic potential of SPECT/CT to detect osteomyelitis in foot or ankle: a systematic review.

The differential diagnostic potential of SPECT/CT to detect osteomyelitis in foot or ankle: a systematic review.

Journal: EFORT open reviews

Published: August 04, 2025

The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.

The German Cancer Consortium (DKTK) multi-center prospective phase 1/2 68Ga-PSMA-11 PET-imaging trial in newly-diagnosed high-risk prostate cancer: Safety and diagnostic accuracy compared to histopathology and their impact on patient management.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 30, 2025

Genotype-specific neoplastic risk profiles in patients with VHL disease.

Genotype-specific neoplastic risk profiles in patients with VHL disease.

Journal: Endocrine-related cancer

Published: October 08, 2024

FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).

FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).

Journal: Nuklearmedizin. Nuclear medicine

Published: April 09, 2024

Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy.

Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [177Lu]Lu-PSMA-617 Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 05, 2023

Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.

Deep learning based automated delineation of the intraprostatic gross tumour volume in PSMA-PET for patients with primary prostate cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 18, 2023

[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer.

[68Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer.

Journal: Archives of gynecology and obstetrics

Published: February 07, 2023

The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT.

The significance of partial volume effect on the estimation of hypoxic tumour volume with [18F]FMISO PET/CT.

Journal: EJNMMI physics

Published: January 16, 2023

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.

Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 01, 2022

Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.

Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 21, 2022

Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.

Ex vivo γH2AX assay for tumor radiosensitivity in primary prostate cancer patients and correlation with clinical parameters.

Journal: Radiation oncology (London, England)

Published: August 22, 2022

Showing 1-12 of 90

Last Updated: 09/26/2026